Green Thumb Industries (GTBIF) Operating Expenses (2019 - 2026)
Green Thumb Industries (GTBIF) posted Operating Expenses of $102.9 million for Q1 2026, down 15.85% on a QoQ basis from $122.3 million in Q4 2025, and up 2.1% year-over-year from $100.8 million in Q1 2025.
Green Thumb Industries (GTBIF) Operating Expenses (2019 - 2026) Analysis & Trends
Green Thumb Industries' Operating Expenses history runs 8 years deep, the most recent figure standing at $102.9 million for Q1 2026.
- Quarterly Operating Expenses rose 2.1% year-over-year to $102.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $439.3 million (up 8.95% YoY) and the FY2025 annual result came in at $437.2 million, up 16.06% from the prior year.
- Operating Expenses was $102.9 million for Q1 2026 at Green Thumb Industries, down from $122.3 million in the prior quarter.
- Across five years, Operating Expenses topped out at $168.5 million in Q4 2022 and bottomed at $63.5 million in Q2 2022.
- A 5-year average of $96.6 million and a median of $96.5 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 126.93% — and 2023, when it plunged 45.19%.
- Green Thumb Industries' Operating Expenses stood at $168.5 million in 2022, then plunged by 45.19% to $92.3 million in 2023, then grew by 9.32% to $101.0 million in 2024, then rose by 21.13% to $122.3 million in 2025, then declined by 15.85% to $102.9 million in 2026.
- Business Quant data shows GTBIF's Operating Expenses at $102.9 million in Q1 2026, $122.3 million in Q4 2025, and $107.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 102.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.91 Mn |
| Dec 31, 2025 | 122.29 Mn |
| Sep 30, 2025 | 107.29 Mn |
| Jun 30, 2025 | 106.82 Mn |
| Mar 31, 2025 | 100.79 Mn |
| Dec 31, 2024 | 100.96 Mn |
| Sep 30, 2024 | 104.97 Mn |
| Jun 30, 2024 | 96.50 Mn |
| Mar 31, 2024 | 74.26 Mn |
| Dec 31, 2023 | 92.35 Mn |
| Sep 30, 2023 | 84.78 Mn |
| Jun 30, 2023 | 84.22 Mn |
| Mar 31, 2023 | 80.52 Mn |
| Dec 31, 2022 | 168.50 Mn |
| Sep 30, 2022 | 82.48 Mn |
| Jun 30, 2022 | 63.54 Mn |
| Mar 31, 2022 | 68.39 Mn |
| Dec 31, 2021 | 74.25 Mn |
| Sep 30, 2021 | 71.45 Mn |
| Jun 30, 2021 | 72.06 Mn |